# Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA Extraction

Jeni Vuong, Jean-Marc Collard, Melissa J. Whaley, Issaka Bassira, Issaka Seidou, Seydou Diarra, Rasmata T. Ouédraogo, Dinanibè Kambiré, Thomas H. Taylor Jr., Claudio Sacchi, et al.

<figure><img src="image_1.png" /></figure>

## To cite this version:

Jeni Vuong, Jean-Marc Collard, Melissa J. Whaley, Issaka Bassira, Issaka Seidou, et al. Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA Extraction. PLoS ONE, 2016, 11 (2), pp.e0147765. 10.1371/journal.pone.0147765. pasteur-03238510

HAL Id: pasteur-03238510

https://riip.hal.science/pasteur-03238510

Submitted on 27 May 2021

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

<figure><img src="image_2.png" /></figure>
<figure><img src="image_3.png" /></figure>

RESEARCH ARTICLE

# Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA Extraction

Jeni Vuong¹, Jean-Marc Collard²,³, Melissa J. Whaley¹, Issaka Bassira³, Issaka Seidou³, Seydou Diarra⁴, Rasmata T. Ouédraogo⁵, Dinanibè Kambiré⁵, Thomas H. Taylor, Jr¹, Claudio Sacchi⁶, Leonard W. Mayer¹, Xin Wang¹*

¹ Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, United States of America, ² Scientific Institute of Public Health, Brussels, Belgium, ³ Centre de Recherche Médicale et Sanitaire, Niamey, Niger, ⁴ Institut National de Recherche en Santé Publique, Bamako, Mali, ⁵ Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle, Ouagadougou, Burkina Faso, ⁶ Instituto Adolfo Lutz, São Paulo, Brazil

* gqe8@cdc.gov

## Abstract

Neisseria meningitidis (Nm), Haemophilus influenzae (Hi), and Streptococcus pneumoniae (Sp) are the lead causes of bacterial meningitis. Detection of these pathogens from clinical specimens using traditional real-time PCR (rt-PCR) requires DNA extraction to remove the PCR inhibitors prior to testing, which is time consuming and labor intensive. In this study, five species-specific (Nm-sodC and -ctrA, Hi-hpd#1 and -hpd#3 and Sp-lytA) and six serogroup-specific rt-PCR tests (A, B, C, W, X, Y) targeting Nm capsular genes were evaluated in the two direct rt-PCR methods using PerfeCTa and 5x Omni that do not require DNA extraction. The sensitivity and specificity of the two direct rt-PCR methods were compared to TaqMan traditional rt-PCR, the current standard rt-PCR method for the detection of meningitis pathogens. The LLD for all 11 rt-PCR tests ranged from 6,227 to 272,229 CFU/ml for TaqMan, 1,824–135,982 for 5x Omni, and 168–6,836 CFU/ml for PerfeCTa. The diagnostic sensitivity using TaqMan ranged from 89.2%-99.6%, except for NmB-csb, which was 69.7%. For 5x Omni, the sensitivity varied from 67.1% to 99.8%, with three tests below 90%. The sensitivity of these tests using PerfeCTa varied from 89.4% to 99.8%. The specificity ranges of the 11 tests were 98.0–99.9%, 97.5–99.9%, and 92.9–99.9% for TaqMan, 5x Omni, and PerfeCTa, respectively. PerfeCTa direct rt-PCR demonstrated similar or better sensitivity compared to 5x Omni direct rt-PCR or TaqMan traditional rt-PCR. Since the direct rt-PCR method does not require DNA extraction, it reduces the time and cost for processing CSF specimens, increases testing throughput, decreases the risk of cross-contamination, and conserves precious CSF. The direct rt-PCR method will be beneficial to laboratories with high testing volume.

<figure><img src="image_4.png" /></figure>

OPEN ACCESS

**Citation:** Vuong J, Collard J-M, Whaley MJ, Bassira I, Seidou I, Diarra S, et al. (2016) Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA Extraction. PLoS ONE 11(2): e0147765. doi:10.1371/journal.pone.0147765

**Editor:** Vishnu Chaturvedi, California Department of Public Health, UNITED STATES

**Received:** October 22, 2015

**Accepted:** January 7, 2016

**Published:** February 1, 2016

**Copyright:** This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

**Data Availability Statement:** All relevant data are within the paper and its Supporting Information files.

**Funding:** The authors have declared that no competing interests exist.

**Competing Interests:** The authors have declared that no competing interests exist.
**Introduction**

*Neisseria meningitidis* (Nm), *Haemophilus influenzae* (Hi), and *Streptococcus pneumoniae* (Sp) are common bacterial meningitis pathogens [1–3]. Traditional real-time PCR (rt-PCR) tests with high sensitivity and specificity have been implemented in many public health laboratories for the detection of these three pathogens [4–8]. Traditional rt-PCR uses DNA polymerase whose activity can be negatively affected by PCR inhibitors in clinical specimens [9–10]. DNA extraction is needed to remove the inhibitors to improve the sensitivity and specificity of traditional rt-PCR. Extracting DNA from clinical specimens is not only expensive but also labor-intensive. A well trained microbiologist can only process up to 40 specimens per day. Because multiple manipulation steps are involved, cross-contamination is often introduced during DNA extraction. In addition, the extraction process may not remove all of the inhibitors or recover 100% of the target DNA [10], which can reduce the diagnostic sensitivity and leads to false-negative results.

Direct rt-PCR uses modified DNA polymerases whose activity can overcome PCR inhibitors present in clinical matrices. These enzymes allow amplification of the target genes directly from clinical specimens without the need to extract DNA [11]. In this study, one traditional and two direct real-time PCR methods were evaluated for detecting *N. meningitidis* and its 6 disease-causing serogroups (A, B, C, W, X and Y), *H. influenzae*, and *S. pneumoniae*. We compared the sensitivity and specificity of the two new direct rt-PCR methods along with our current traditional rt-PCR method.

**Materials and Methods**

**Ethics Statement**

Ethics approval was not obtained from the CDC Institutional Review Board (IRB) for clinical specimens reported in this study because the specimens sent to CDC were existing specimens collected for clinical purposes. CDC investigators had no access to any identifiable private information about people. CDC IRB approval was not sought for cerebral spinal fluid specimens from Brazil, Burkina Faso, Mali and Niger specimens because these cerebral spinal fluid specimens were not considered human specimens, as they do not meet the definition of a living human subject. These specimens have been tested at the respective countries as part of their routine surveillance. These specimens were not collected specifically for this study.

**Study Design**

The traditional rt-PCR method used the TaqMan® Universal PCR master mix (Applied Biosystems, Foster City, CA) and extracted DNA as template. Traditional singleplex rt-PCR tests targeting 11 genes, have been published and implemented in many domestic and international public health laboratories (S1 Table) [4–8]. These 11 tests are considered as the standard rt-PCR method for detecting *N. meningitidis* and its 6 main disease-causing serogroups (A, B, C, W, X and Y), *H.influenzae*, and *S. pneumoniae*.

The two direct rt-PCR methods used either the 5x Omni Klentaq LA PCR Kit (DNA Polymerase Technology, St. Louis, MO) or PerfeCTa qPCR ToughMix (Quanta Biosciences, Gaithersburg, MD) to amplify the 11 target genes directly from CSF in singleplex reactions. The methods are described below.

Real-time PCR tests targeting each of the 11 genes for the pathogens described above were evaluated for both direct rt-PCR methods. The name of each PCR test include its target species or serogroup and the gene. Final concentration of primers and probe for each rt-PCR test was optimized by testing in the ranges of 100–900 nM for primers and 100–300 nM for probe
<table><caption>Table 1. Final concentrations of primers and probes for the real-time PCR tests for detection of *Neisseria meningitidis* and its 6 serogroups, *Haemophilus influenzae*, and *Streptococcus pneumoniae* using traditional and direct methods<sup>a</sup>.</caption><thead><tr><th>PCR tests</th><th>Traditional TaqMan (Fw/Rv/Pb nM)<sup>a</sup></th><th>Direct 5x Omni (Fw/Rv/Pb nM)</th><th>Direct PerfeCTa (Fw/Rv/Pb nM)</th></tr></thead><tbody><tr><td>Nm-ctrA</td><td>300/900/100</td><td>900/600/100</td><td>300/600/200</td></tr><tr><td>Nm-sodC</td><td>300/600/100</td><td>Not compatible</td><td>300/300/200</td></tr><tr><td>Hi-hpd #1</td><td>300/100/200</td><td>900/300/900</td><td>600/600/300</td></tr><tr><td>Hi-hpd #3</td><td>100/300/100</td><td>Not compatible</td><td>100/900/300</td></tr><tr><td>Sp-lytA</td><td>200/200/200</td><td>600/600/600</td><td>300/600/200</td></tr><tr><td>NmA-csaB</td><td>300/900/100</td><td>900/600/100</td><td>900/600/300</td></tr><tr><td>NmB-csb</td><td>300/300/100</td><td>600/900/200</td><td>900/300/200</td></tr><tr><td>NmC-csc</td><td>900/300/100</td><td>900/300/300</td><td>300/300/300</td></tr><tr><td>NmW-csw</td><td>100/900/200</td><td>600/600/200</td><td>300/100/200</td></tr><tr><td>NmX-csxB</td><td>900/900/100</td><td>600/600/200</td><td>600/600/200</td></tr><tr><td>NmY-csy</td><td>900/600/100</td><td>600/900/300</td><td>900/300/300</td></tr></tbody></table>

doi:10.1371/journal.pone.0147765.t001

(Table 1). Each rt-PCR reaction was prepared in a final volume of 25µl, containing 2 µl of CSF (S2 Table), and tested on the Stratagene Mx3005P (Agilent Technology, Santa Clara, CA) using the cycling conditions described in S3 Table.

To determine the lower limit of detection (LLD), target bacterial pathogens were first suspended in Brian Heart Infusion (BHI) broth, which was then serially diluted with CSF and BHI broth in 10-fold increments. The BHI dilutions ($10^{-5}$-$10^{-7}$) were plated onto their respective media and incubated at 35°C with 5% CO$_2$ for 24 hours for enumeration of colony forming units per milliliter (CFU/ml). The CSF dilutions ($10^{-1}$-$10^{-7}$) were tested with direct rt-PCR using 5x Omni and PerfeCTa. To assess the LLD by traditional PCR method using ABI master mix, DNA was extracted from 200 µl of the $10^{-1}$ CSF dilution, eluted in 100 µl of elution buffer, and was then serially diluted with PCR grade water in 10-fold increments using QIAamp DNA Mini Kit (QIAGEN, Valencia, California). Traditional rt-PCR was performed on DNA dilutions ($10^{-1}$-$10^{-7}$). Each CSF or DNA dilution was tested by rt-PCR in triplicates. The LLD was defined as the number of CFU/ml that yielded a cycle threshold (C$_t$) value of 35.

To determine the diagnostic sensitivity and specificity of the traditional and direct rt-PCR methods, CSF from meningitis patients were obtained from the following countries as part of their routine surveillance collection: Mali (n = 113), Burkina Faso (n = 131), Brazil (n = 82), Niger (n = 53), and the United States (n = 42). These CSFs had been tested previously at the respective countries using various microbiological tests such as culture, latex agglutination, counterimmunoelectrophoresis, and/or PCR. As these microbiological tests were not standardized in all countries and their sensitivity and specificity vary from country to country, none of the results from these tests were used as the reference standard due to their imperfect sensitivity and specificity. As a result, the diagnostic sensitivity and specificity were calculated using latent class analysis (LCA) which uses an internal reference standard based on the statistical model [12–13]. LCA uses data from at least 3 conditionally independent methods to determine the sensitivity and specificity without taking into consideration the laboratories’ results from the microbiological tests described above [12]. Since 5x Omni direct real-time PCR was not compatible for Nm-sodC and Hi-hpd #3 tests, the laboratories’ results were used as the reference standard to obtain sensitivity and specificity using conventional 2 x 2 tables.

<footnote><sup>a</sup> Fw = Forward primer, Rv = Reverse primer; Pb = Probe</footnote>
## Results and Discussion

The LLD for all 11 rt-PCR tests ranged from 6,227 to 272,229 CFU/ml for TaqMan traditional rt-PCR, 1,824–135,982 for 5x Omni direct rt-PCR, and 168–6,836 CFU/ml for PerfeCTa direct rt-PCR (Table 2). The diagnostic sensitivity of the 11 tests using TaqMan traditional rt-PCR ranged from 89.2%-99.6%, except for NmB-csb, which was 69.7% (Table 3). For 5x Omni direct rt-PCR, the sensitivity varied from 67.1% to 99.8%, with three tests below 90%. The sensitivity of these tests using PerfeCTa direct rt-PCR varied from 89.4% to 99.8%. The specificity ranges of the 11 tests were 98.0–99.9%, 97.5–99.9%, and 92.9–99.9% for TaqMan traditional rt-PCR, 5x Omni direct rt-PCR, and PerfeCTa direct rt-PCR, respectively (Table 3). Because Nm-sodC and Hi-hpd #3 tests were unable to amplify their target genes using 5x Omni direct rt-PCR, their sensitivity and specificity could not be calculated using LCA, which requires the results of at least 3 methods [13]. Therefore, the diagnostic sensitivity and specificity of Nm-sodC and Hi-hpd #3 were calculated using the non-PCR tests (culture, latex, or counterimmunoelectro-phoresis) as the composite reference standard. The diagnostic sensitivity of the Nm-sodC assay was 100% for TaqMan traditional rt-PCR and PerfeCta direct rt-PCR methods; the diagnostic specificity was 96% and 92% for TaqMan traditional rt-PCR and PerfeCta direct rt-PCR methods, respectively. The diagnostic sensitivity of Hi-hpd #3 was 83% and 84.9% for TaqMan traditional rt-PCR and PerfeCta direct rt-PCR methods, respectively, and the diagnostic specificity was 100% for both methods.

Although culture is considered the gold standard, culture is not always a perfect reference standard for calculating the diagnostic sensitivity and specificity due to the low culture rate (high false negative rate) in many regions. In contrast, LCA has become a preferred method for comparing the sensitivity and specificity for three or more independent methods. True positive and negative results are defined by the consensus of the methods that were evaluated instead of the reference standard, whose low sensitivity can directly affect the results of the evaluated methods. PerfeCTa direct rt-PCR detected more positives than TaqMan traditional and 5x

<table><caption>Table 2. Lower limits of detection for the real-time PCR tests using traditional and direct methods.ª</caption><thead><tr><th>PCR Tests</th><th>Traditional TaqMan (CFU/ml)</th><th>Direct 5x Omni (CFU/ml)</th><th>Direct PerfeCTa (CFU/ml)</th></tr></thead><tbody><tr><td>Nm-ctrA</td><td>24,098</td><td>5,145</td><td>197</td></tr><tr><td>Nm-sodC</td><td>18,951</td><td>Not compatible</td><td>329</td></tr><tr><td>Hi-hpd #1</td><td>60,792</td><td>39,818</td><td>3,177</td></tr><tr><td>Hi-hpd #3</td><td>6,227</td><td>Not compatible</td><td>954</td></tr><tr><td>Sp-lytA</td><td>63,861</td><td>86,755</td><td>6,836</td></tr><tr><td>NmA-csaB</td><td>19,754</td><td>6,341</td><td>906</td></tr><tr><td>NmB-csb</td><td>178,021</td><td>28,392</td><td>1,606</td></tr><tr><td>NmC-csc</td><td>10,089</td><td>135,982</td><td>925</td></tr><tr><td>NmW-csw</td><td>272,229</td><td>10,365</td><td>610</td></tr><tr><td>NmX-csxB</td><td>9,618</td><td>27,699</td><td>174</td></tr><tr><td>NmY-csy</td><td>73,264</td><td>1,824</td><td>168</td></tr></tbody></table>

<footnote>ª Bacterial suspensions of known concentrations were prepared in Brain and Heart Infusion (BHI) broth. Ten-fold serial dilutions of BHI bacterial suspension were prepared with BHI broth and cerebrospinal fluid (CSF) for enumeration of colony forming units per milliliter (CFU/ml) and PCR testing in triplicate, respectively. Spiked CSF dilutions were tested by direct real-time PCR using 5x Omni and PerfeCTa master mix, whereas extracted DNA from the same spiked CSF dilutions was tested by traditional real-time PCR using TaqMan master mix. The CFU/ml of each BHI dilution was calculated from enumeration and plotted against the mean cycle threshold for each dilution based on the PCR triplicate testing. The lower limit of detection is the bacterial concentration yielding a C<sub>t</sub> = 35.</footnote>
<table><caption>Table 3. Diagnostic sensitivity and specificity for the real-time PCR tests by latent class analysis.</caption><thead><tr><th rowspan="2">PCR Tests</th><th colspan="4">Sensitivity (95% CI)</th><th colspan="4">Specificity (95% CI)</th></tr><tr><th>N<sup>a</sup></th><th>Traditional TaqMan</th><th>Direct 5x Omni</th><th>Direct PerfeCTa</th><th>N<sup>a</sup></th><th>Traditional TaqMan</th><th>Direct 5x Omni</th><th>Direct PerfeCTa</th></tr></thead><tbody><tr><td>Nm-ctrA</td><td>78</td><td>99.6% (95.5–100)</td><td>99.8% (95.5–100)</td><td>99.8% (95.5–100)</td><td>50</td><td>99.3% (92.5–100)</td><td>97.5% (88.7–99.9)</td><td>93.3% (82.5–98.7)</td></tr><tr><td>Nm-ctrA<sup>b</sup></td><td>78</td><td>99.8% (95.5–100)</td><td>99.8% (95.5–100)</td><td>99.8% (95.5–100)</td><td>48</td><td>99.3% (92.5–100)</td><td>99.3% (88.7–99.9)</td><td>99.3% (85.5–99.5)</td></tr><tr><td>Nm-sodC<sup>c</sup></td><td>77</td><td>NA</td><td>Not compatible</td><td>NA</td><td>50</td><td>NA</td><td>Not compatible</td><td>NA</td></tr><tr><td>Hi-hpd #1</td><td>53</td><td>96.2% (87.4–99.9)</td><td>96% (87.4–99)</td><td>99.2% (91.6–100)</td><td>50</td><td>98.1% (91.2–100)</td><td>99.7% (94.1–100)</td><td>95.3% (86.3–99)</td></tr><tr><td>Hi-hpd #3<sup>c</sup></td><td>53</td><td>NA</td><td>Not compatible</td><td>NA</td><td>50</td><td>NA</td><td>Not compatible</td><td>NA</td></tr><tr><td>Sp-lytA</td><td>114</td><td>98.8% (94.7–100)</td><td>92.9% (86.4–97.2)</td><td>99.7% (96.4–100)</td><td>50</td><td>98% (91.3–100)</td><td>99.5% (94.2–100)</td><td>97.9% (91.3–100)</td></tr><tr><td>NmA-csaB</td><td>8</td><td>94.9% (63.1–100)</td><td>94.9% (63.1–100)</td><td>94.9% (63.1–100)</td><td>50</td><td>99.9% (92.9–100)</td><td>99.9% (92.9–100)</td><td>99.9% (92.9–100)</td></tr><tr><td>NmB-csb</td><td>38</td><td>69.7% (53–84.1)</td><td>80.4% (64.8–92)</td><td>99.2% (90.5–100)</td><td>50</td><td>99.7% (93–100)</td><td>99.7% (93–100)</td><td>99.6% (93–100)</td></tr><tr><td>NmC-csc</td><td>62</td><td>99.6% (94.1–100)</td><td>99.6% (94.1–100)</td><td>99.6% (94.1–100)</td><td>50</td><td>99.5% (93–100)</td><td>99.5% (93–100)</td><td>99.5% (93–100)</td></tr><tr><td>NmW-csw</td><td>42</td><td>89.2% (75.8–97.1)</td><td>68.8% (51.3–82.5)</td><td>99.3% (91–100)</td><td>50</td><td>99.6% (93.2–100)</td><td>99.7% (93.2–100)</td><td>92.9% (84.1–98.8)</td></tr><tr><td>NmW-csw<sup>b</sup></td><td>42</td><td>89.2% (75.8–97.1)</td><td>68.8% (52.4–83)</td><td>99.3% (91–100)</td><td>47</td><td>99.6% (93.3–100)</td><td>99.7% (93.3–100)</td><td>99.5% (84.3–98.8)</td></tr><tr><td>NmX-csxB</td><td>31</td><td>99% (88.8–100)</td><td>95.8% (83.3–99.9)</td><td>99% (88.4–100)</td><td>50</td><td>99.6% (92.9–100)</td><td>99.6% (92.9–100)</td><td>97.6% (89.4–99.9)</td></tr><tr><td>NmY-csy</td><td>5</td><td>89.4% (39.8–100)</td><td>67.1% (19.4–99.4)</td><td>89.4% (39.8–100)</td><td>50</td><td>99.9% (93–100)</td><td>99.9% (93–100)</td><td>99.9% (93–100)</td></tr></tbody></table>

doi:10.1371/journal.pone.0147765.t003

Omni direct rt-PCR methods, which explains the lower specificity of the PerfeCTa NmW-csw and Nm-ctrA tests (92.9% and 93.3%, respectively). This was attributed to a few specimens that were negative by TaqMan and 5x Omni rt-PCR methods, yet were positive for one or more test (s) using PerfeCTa (Table 4). A specimen containing encapsulated Nm should be positive for sodC or ctrA and the serogroup specific gene. The presence of this pattern (Table 4) suggests that the PerfeCTa results were true positives while both the TaqMan and 5x Omni results were falsely negative. A revised LCA analysis excluding those specimens produced a specificity of 99.3% for Nm-ctrA and ~99.6% for NmW-csw for all 3 methods (Table 3).

While additional chemical, physical, or enzymatic lysis is recommended to increase DNA yield from gram-positive bacteria such as Sp and improve PCR diagnostic sensitivity and specificity, our data demonstrate that the PerfeCTa direct rt-PCR was able to detect Sp without compromising sensitivity. Although only a small number of positive CSF specimens for NmA-csaB (n = 8) and NmY-csy (n = 5) serogroups were tested, the results suggest that PerfeCTa will perform comparably for the detection of these two serogroups since PerfeCTa direct rt-PCR detects other serogroups with good sensitivity (Table 3). However, additional evaluation on a larger number of CSF specimens will be required to better assess the sensitivity and specify of the two tests.

PerfeCTa direct rt-PCR did not cross-detect other bacterial species (S4 Table) except for a veterinary pathogen, *Actinobacillus pleuropneumoniae*, which was positive for Nm-ctrA (C<sub>t</sub> = 33) and Nm-sodC (C<sub>t</sub> = 35), and *Aggregatibacter aphrophilus*, which was positive for *hpd*. These results were also previously observed with traditional rt-PCR [7]. *A. aphrophilus* has been implicated with causing brain abscesses [14]; association with meningitis has not been reported. While this is a limitation of the assay, this situation is rarely encountered as these pathogens are unlikely to be present in human CSF.

<footnote>a N = number of cerebrospinal fluid specimens tested. All specimens were collected from meningitis patients.</footnote>

<footnote>b Recalculated diagnostic specificity by latent class analysis after exclusion of four specimens that were positive by direct real-time PCR using PerfeCTa but negative by traditional real-time PCR using TaqMan and direct real-time PCR using 5x Omni (Table 4).</footnote>

<footnote>c NA = Since direct real-time PCR using 5x Omni was not compatible with these targets, Latent Class Analysis (LCA) could not be performed on these tests. Instead, the sensitivity and specificity of these tests were calculated using non-PCR tests as the reference standard as described in the text.</footnote>
<table><caption>Table 4. Cerebrospinal fluid specimens that were positive by direct real-time PCR using PerfeCTa and negative by traditional real-time PCR using TaqMan or direct real-time PCR using 5x Omni.</caption><thead><tr><th>Specimen</th><th>Test</th><th>Lab ID</th><th>TaqMan</th><th>5x Omni</th><th>PerfeCTa</th></tr></thead><tbody><tr><td rowspan="2">1</td><td>NmW-csw</td><td>M26789</td><td>Negative</td><td>Negative</td><td>Positive<sup>a</sup></td></tr><tr><td>Nm-ctrA</td><td>M26789</td><td>Negative</td><td>Positive</td><td>Positive<sup>b</sup></td></tr><tr><td rowspan="2">2</td><td>NmW-csw</td><td>M26790</td><td>Negative</td><td>Negative</td><td>Positive<sup>a</sup></td></tr><tr><td>Nm-ctrA</td><td>M26790</td><td>Positive</td><td>Positive</td><td>Positive<sup>b</sup></td></tr></tbody></table>

doi:10.1371/journal.pone.0147765.t004

Real-time PCR has been implemented in clinical laboratories for the detection of bacterial meningitis pathogens. In regions with high burdens of disease, laboratories are required to test thousands of CSF specimens while trying to provide timely laboratory results. Extracting DNA from 20 CSF specimens takes about 3 or more hours, which is the bottleneck of traditional rt-PCR. Direct rt-PCR allows the detection of bacterial pathogens directly from CSF specimens without DNA extraction thereby reducing processing time, cost, labor, and risk of cross-contamination. Direct rt-PCR improves the testing throughput and provides a more robust method for the laboratories with high volume of specimens. Because there is no DNA loss with the elimination of DNA extraction, lower numbers of bacterial cells are detected compared to the traditional rt-PCR, well within the range detected by culture [15]. In addition, direct rt-PCR conserves precious CSF specimens as it only requires 2 µl of CSF per reaction.

In conclusion, we have demonstrated that the direct rt-PCR method detects meningitis pathogens with similar or better sensitivity and can replace the current traditional rt-PCR to improve the laboratory testing capacity. To further improve the PCR testing efficiency, we are currently validating direct rt-PCR in multiplex for the detection of bacterial meningitis pathogens and their serogroup and serotypes.

## Supporting Information

S1 Table. Primers and probes used for rt-PCR assays.
(DOCX)

S2 Table. Reaction assembly for traditional and two direct real-time PCR methods.
(DOCX)

S3 Table. Cycling conditions for the traditional and two direct real-time PCR methods.
(DOCX)

S4 Table. Panel of 25 species representing 14 different genera of bacterial isolates used for cross-reactivity testing.
(DOCX)

## Acknowledgments

We would like to thank Brian Harcourt, Nong Shang, and Melissa Lewis from the Centers for Disease Control and Prevention; Rosemary Maxwell and Samantha Thomas from Agnes Scott; and Tamboura Mamadou from the National Reference Laboratory of Meningitis in Burkina Faso for their contributions to this project. Additionally, we would like to thank Centre Hospitalier Universitaire Yalgado Ouédraogo and Centre Muraz in Burkina Faso for providing the

<footnote>a Two NmW-csw specimens tested positive only by PerfeCTa yet were negative by both TaqMan and 5x Omni.</footnote>

<footnote>b Since the specimens were also positive by a second PCR target, Nm-ctrA, this provides additional assurance that the specimens are positive for NmW-csw using PerfeCTa.</footnote>
CSF specimens for this study. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.

## Author Contributions

Conceived and designed the experiments: JV J-MC MJW SD RTO CS LWM XW. Performed the experiments: JV MJW IB IS DK. Analyzed the data: JV MJW THT XW. Contributed reagents/materials/analysis tools: JV J-MC MJW SD RTO CS THT LWM XW. Wrote the paper: JV XW. Assisted with editing, finalizing, & giving critical feedback on the scientific content of the manuscript: JV J-MC MJW IB IS SD RTO DK THT CS LWM XW.

## References

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N et al. Burden of disease caused by *Streptococcus pneumoniae* in children younger than 5 years: global estimates. Lancet. 2009; 374:893-902. doi: 10.1016/S0140-6736(09)61204-6 PMID: 19748398

2. Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by *Haemophilus influenzae* type b in children younger than 5 years: global estimates. Lancet 2009; 374:903-911. doi: 10.1016/S0140-6736(09)61203-4 PMID: 19748399

3. Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, et al. Changes in *Neisseria meningitidis* disease epidemiology in the United States, 1998-2007: Implications for prevention of meningococcal disease. Clin. Infect. Dis. 2010; 50:184-191. doi: 10.1086/649209 PMID: 20001736

4. Mothershed EA, Sacchi CT, Whitney AM, Barnett GA, Ajello GW, Schmink S, et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. Jour of Clin Micro. 2004; 42:320-328.

5. Carvalho MG, Tondella ML, McCaustland K, Weidlich L, McGee L, Mayer LW, et al. Evaluation and improvement of real-time PCR assays targeting *lytA*, *ply*, and *psaA* genes for detection of pneumococcal DNA. Jour of Clin Micro. 2007; 45:2460-2466.

6. Dolan Thomas J, Hatcher CP, Satterfield DA, Theodore MJ, Bach MC, Linscott KB, et al. sodC-based real-time PCR for detection of Neisseria meningitidis. PLoS One 6:e19361. 2011. doi: 10.1371/journal.pone.0019361 PMID: 21573213

7. Wang X, Mair R, Hatcher C, Theodore MJ, Edmond K, Wu HM, et al. Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect *Haemophilus influenzae*. Intl Jour of Med Micro. 2011; 301:303-309.

8. Wang X, Theodore MJ, Mair R, Trujillo-Lopez E, du Plessis M, Wolter N, et al. Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens. J Clin Microbiol. 2012; 50:702-708. doi: 10.1128/JCM.06087-11 PMID: 22170919

9. Akane A, Matsubara K, Nakamura H, Takahashi S, Kimura K. Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification. J Forensic Sci. 1994; 39:362-372. PMID: 8195750

10. Wilson IG. Inhibition and facilitation of nucleic acid amplification. Appl Environ Microbiol. 1997; 63:3741-3751. PMID: 9327537

11. Kermekchiev MB, Kirilova LI, Vail EE, Barnes WM. Mutants of Taq DNA polymerase resistant to PCR inhibitors allow DNA amplification from whole blood and crude soil samples. Nucl. Acids Res. 37:e40 E pub. 2009. doi: 10.1093/nar/gkn1055 PMID: 19208643

12. Baughman AL, Bisgard KM, Cortese MM, Thompson WW, Sanden GN, Strebel PM. Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin Vaccine Immunol. 2008; 15:106-114. PMID: 17989336

13. Hadgu A, Dendukuri N, Hilden J. Evaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test—a review of the statistical and epidemiologic issues. Epidemiology. 2005; 16:604-612. PMID: 16135935

14. Nørskov-Lauritsen N. Classification, identification, and clinical significance of Haemophilus and Aggregatibacter Species with host specificity for humans. CMR. 2014; 27:214-240.

15. La Scolea LJ and Dryja D Jr. Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J. Clin. Microbiol. 1984; 19:187-190. PMID: 6365957